Mirae Asset Global Investments
CORT icon

Mirae Asset Global Investments’s Corcept Therapeutics CORT Stock Holding History

Mirae Asset Global Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,726
Closed -$824K – 1741
2024
Q1 		$824K Hold
37,726
– – ﹤0.01% 1643
2023
Q4 		$1.23M Hold
37,726
– – ﹤0.01% 1515
2023
Q3 		$1.03M Hold
37,726
– – ﹤0.01% 1510
2023
Q2 		$839K Hold
37,726
– – ﹤0.01% 1673
2023
Q1 		$817K Buy
37,726
+862
+2% +$18.9K ﹤0.01% 1645
2022
Q4 		$749K Hold
36,864
– – ﹤0.01% 1666
2022
Q3 		$945K Buy
36,864
+10,880
+42% +$291K ﹤0.01% 1512
2022
Q2 		$618K Buy
+25,984
New +$566K ﹤0.01% 1650

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return